Clinical Trial Update: Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing two golimumab dosing regimens for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Simponi (golimumab)

Snippet

Sponsor: David Drobne | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED